[1]
Davis, F.G.; Malmer, B.S.; Aldape, K.; Barnholtz-Sloan, J.S.; Bondy, M.L.; Brannstrom, T.; Bruner, J.M.; Burger, P.C.; Collins, V.P.; Inskip, P.D. Issues of diagnostic review in brain tumor studies: From the brain tumor epidemiology consortium. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 484-489.
[2]
Rinaldi, M.; Caffo, M.; Minutoli, L.; Marini, H.; Abbritti, R.V.; Squadrito, F.; Trichilo, V.; Valenti, A.; Barresi, V.; Altavilla, D. Ros and brain gliomas: An overview of potential and innovative therapeutic strategies. Int. J. Mol. Sci., 2016, 17.
[3]
Illan-Cabeza, N.A.; Garcia-Garcia, A.R.; Martinez-Martos, J.M.; Ramirez-Exposito, M.J.; Pena-Ruiz, T.; Moreno-Carretero, M.N. A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-n3)-triphenylphosphine-gold(i): Structural studies and in vivo biological effects against experimental glioma. Eur. J. Med. Chem., 2013, 64, 260-272.
[4]
Martinez-Martos, J.M.; Mayas, M.D.; Carrera, P.; de Saavedra, J.M.A.; Sanchez-Agesta, R.; Arrazola, M.; Ramirez-Exposito, M.J. Phenolic compounds oleuropein and hydroxytyrosol exert differential effects on glioma development via antioxidant defense systems. J. Funct. Foods, 2014, 11, 221-234.
[5]
Ramirez-Exposito, M.J.; Martinez-Martos, J.M. Anti-inflammatory and antitumor effects of hydroxytyrosol but not oleuropein on experimental glioma in vivo. A putative role for the renin-angiotensin system. Biomedicines, 2018, 6.
[6]
Acharya, A.; Das, I.; Chandhok, D.; Saha, T. Redox regulation in cancer: A double-edged sword with therapeutic potential. Oxid. Med. Cell. Longev., 2010, 3, 23-34.
[7]
Herrera, A.C.; Panis, C.; Victorino, V.J.; Campos, F.C.; Colado-Simao, A.N.; Cecchini, A.L.; Cecchini, R. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunol. Immunother., 2012, 61, 2193-2201.
[8]
Papacocea, T.; Papacocea, R.; Badarau, A.; Ion, A.D.; Buraga, I.; Gaman, L.; Papacocea, A. Oxidative stress and antioxidants in brain tumors. Therapeutics, Pharmacol. Clin. Toxicol. , 2011, XV, 234-239.
[9]
Rajaraman, P.; Hutchinson, A.; Rothman, N.; Black, P.M.; Fine, H.A.; Loeffler, J.S.; Selker, R.G.; Shapiro, W.R.; Linet, M.S.; Inskip, P.D. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro-oncol., 2008, 10, 709-715.
[10]
Kryston, T.B.; Georgiev, A.B.; Pissis, P.; Georgakilas, A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res., 2011, 711, 193-201.
[11]
Pelicano, H.; Feng, L.; Zhou, Y.; Carew, J.S.; Hileman, E.O.; Plunkett, W.; Keating, M.J.; Huang, P. Inhibition of mitochondrial respiration: A novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J. Biol. Chem., 2003, 278, 37832-37839.
[12]
de Miguel, M.; Cordero, M.D. Oxidative therapy against cancer.Oxidative estress and diseases; Lushchak, V., Ed. In Tech: Croatia,. , 2012, pp. 497-520.
[13]
Liang, L.P.; Patel, M. Seizure-induced changes in mitochondrial redox status. Free Radic. Biol. Med., 2006, 40, 316-322.
[14]
Ramirez-Exposito, M.J.; Martinez-Martos, J.M. The delicate equilibrium between oxidants and antioxidants in brain glioma. Curr. Neuropharmacol., 2018.
[15]
Watson, J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol., 2013, 3, 120144.
[16]
Druckrey, H.; Ivankovic, S.; Preussmann, R. Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature, 1966, 210, 1378-1379.
[17]
Koestner, A.; Swenberg, J.A.; Wechsler, W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in sprague-dawley rats. Am. J. Pathol., 1971, 63, 37-56.
[18]
Schiffer, D.; Giordana, M.T.; Pezzotta, S.; Lechner, C.; Paoletti, P. Cerebral tumors induced by transplacental enu: Study of the different tumoral stages, particularly of early proliferations. Acta Neuropathol., 1978, 41, 27-31.
[19]
Zook, B.C.; Simmens, S.J.; Jones, R.V. Evaluation of enu-induced gliomas in rats: Nomenclature, immunochemistry, and malignancy. Toxicol. Pathol., 2000, 28, 193-201.
[20]
Mahlke, M.A.; Cortez, L.A.; Ortiz, M.A.; Rodriguez, M.; Uchida, K.; Shigenaga, M.K.; Lee, S.; Zhang, Y.; Tominaga, K.; Hubbard, G.B. The anti-tumor effects of calorie restriction are correlated with reduced oxidative stress in enu-induced gliomas. Pathobiol. Aging Age Relat. Dis., 2011, 1.
[21]
Kokkinakis, D.M.; Rushing, E.J.; Shareef, M.M.; Ahmed, M.M.; Yang, S.; Singha, U.K.; Luo, J. Physiology and gene expression characteristics of carcinogen-initiated and tumor-transformed glial progenitor cells derived from the cns of methylnitrosourea (mnu)-treated sprague-dawley rats. J. Neuropathol. Exp. Neurol., 2004, 63, 1182-1199.
[22]
Bulnes, S.; Lafuente, J.V. Vegf immunopositivity related to malignancy degree, proliferative activity and angiogenesis in enu-induced gliomas. J. Mol. Neurosci., 2007, 33, 163-172.
[23]
Bartsch, H.; Hietanen, E.; Malaveille, C. Carcinogenic nitrosamines: Free radical aspects of their action. Free Radic. Biol. Med., 1989, 7, 637-644.
[24]
Hietanen, E.; Bartsch, H. Gastrointestinal cancers: Role of nitrosamines and free radicals. Eur. J. Cancer Prev., 1992, 1(Suppl. 3), 51-54.
[25]
Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, 7th edition. ed.; Elsevier Academic Press: Amsterdam ; Boston, 2013, p. 472 pages.
[26]
Martinez-Martos, J.M.; Ramirez-Exposito, M.J.; Mayas-Torres, M.D.; Garcia-Lopez, M.J.; Ramirez-Sanchez, M. Utility of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (mtt) assay to measure mitochondrial activity in k+- and atp-stimulated rodent cortex synaptosomes. Neurosci. Res. Commun., 2000, 27, 103-107.
[27]
Ramirez-Exposito, M.J.; Urbano-Polo, N.; Duenas, B.; Navarro-Cecilia, J.; Ramirez-Tortosa, C.; Martin-Salvago, M.D.; Martinez-Martos, J.M. Redox status in the sentinel lymph node of women with breast cancer. Ups. J. Med. Sci., 2017, 122, 207-216.
[28]
Ramirez-Exposito, M.J.; Sanchez-Lopez, E.; Cueto-Urena, C.; Duenas, B.; Carrera-Gonzalez, P.; Navarro-Cecilia, J.; Mayas, M.D.; Arias de Saavedra, J.M.; Sanchez-Agesta, R.; Martinez-Martos, J.M. Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy. Exp. Gerontol., 2014, 58, 34-42.
[29]
Puertas, M.C.; Martinez-Martos, J.M.; Cobo, M.P.; Carrera, M.P.; Mayas, M.D.; Ramirez-Exposito, M.J. Plasma oxidative stress parameters in men and women with early stage alzheimer type dementia. Exp. Gerontol., 2012, 47, 625-630.
[30]
Visioli, F.; Bellomo, G.; Galli, C. Free radical-scavenging properties of olive oil polyphenols. Biochem. Biophys. Res. Commun., 1998, 247, 60-64.
[31]
Ikeno, Y.; Shimokawa, I.; Higami, Y.; Ikeda, T. Gfap expression in the subcutaneous tumors of immature glial cell line (hits glioma) derived from enu-induced rat glioma. J. Neurooncol., 1993, 17, 191-204.
[32]
Kish, P.E.; Blaivas, M.; Strawderman, M.; Muraszko, K.M.; Ross, D.A.; Ross, B.D.; McMahon, G. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: A model for experimental therapeutics of low-grade gliomas. J. Neurooncol., 2001, 53, 243-257.
[33]
Slikker, W., III; Mei, N.; Chen, T. N-ethyl-n-nitrosourea (enu) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol. Sci., 2004, 81, 112-120.
[34]
Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer, 2007, 121, 2381-2386.
[35]
Zhang, Y.; Chen, S.Y.; Hsu, T.; Santella, R.M. Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis, 2002, 23, 207-211.
[36]
Zengin, E.; Atukeren, P.; Kokoglu, E.; Gumustas, M.K.; Zengin, U. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues. Clin. Neurol. Neurosurg., 2009, 111, 345-351.
[37]
Cirak, B.; Inci, S.; Palaoglu, S.; Bertan, V. Lipid peroxidation in cerebral tumors. Clin. Chim. Acta, 2003, 327, 103-107.
[38]
Guo, J.; Prokai, L. To tag or not to tag: A comparative evaluation of immunoaffinity-labeling and tandem mass spectrometry for the identification and localization of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation. J. Proteomics, 2011, 74, 2360-2369.
[39]
Amstad, P.; Moret, R.; Cerutti, P. Glutathione peroxidase compensates for the hypersensitivity of cu,zn-superoxide dismutase overproducers to oxidant stress. J. Biol. Chem., 1994, 269, 1606-1609.
[40]
Sun, Y.; St Clair, D.K.; Xu, Y.; Crooks, P.A.; St Clair, W.H. A nadph oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells. Cancer Res., 2010, 70, 2880-2890.
[41]
Shi, J.; Sun, B.; Shi, W.; Zuo, H.; Cui, D.; Ni, L.; Chen, J. Decreasing gsh and increasing ros in chemosensitivity gliomas with idh1 mutation. Tumour Biol., 2015, 36, 655-662.
[42]
Navarro, J.; Obrador, E.; Carretero, J.; Petschen, I.; Avino, J.; Perez, P.; Estrela, J.M. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic. Biol. Med., 1999, 26, 410-418.
[43]
Gilca, M.; Stoian, I.; Lixandru, D.; Gaman, L.; Virgolici, B.; Atanasiu, V. Protection of erythrocyte membrane against oxidative damage by geriforte in healthy human subjects. Rom. J. Intern. Med., 2009, 47, 289-295.
[44]
Che, M.; Wang, R.; Li, X.; Wang, H.Y.; Zheng, X.F.S. Expanding roles of superoxide dismutases in cell regulation and cancer. Drug Discov. Today, 2016, 21, 143-149.
[45]
Popov, B.; Gadjeva, V.; Valkanov, P.; Popova, S.; Tolekova, A. Lipid peroxidation, superoxide dismutase and catalase activities in brain tumor tissues. Arch. Physiol. Biochem., 2003, 111, 455-459.
[46]
Aggarwal, S.; Subberwal, M.; Kumar, S.; Sharma, M. Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidase. J. Cancer Res. Ther., 2006, 2, 24-27.
[47]
Del Maestro, R.F.; McDonald, W.; Anderson, R. In Oxy radicals and their scavenger systems; Greenwald, R.; Cohen, G., Eds.; Elsevier: New York, 1983, pp. 28-35.
[48]
Crapo, J.D.; Oury, T.; Rabouille, C.; Slot, J.W.; Chang, L.Y. Copperzinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA, 1992, 89, 10405-10409.
[49]
MacMillan-Crow, L.A.; Thompson, J.A. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (y34f) by peroxynitrite. Arch. Biochem. Biophys., 1999, 366, 82-88.
[50]
Kienhofer, J.; Haussler, D.J.; Ruckelshausen, F.; Muessig, E.; Weber, K.; Pimentel, D.; Ullrich, V.; Burkle, A.; Bachschmid, M.M. Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J., 2009, 23, 2034-2044.
[51]
Lund, D.D.; Chu, Y.; Miller, J.D.; Heistad, D.D. Protective effect of extracellular superoxide dismutase on endothelial function during aging. Am. J. Physiol. Heart Circ. Physiol., 2009, 296, H1920-H1925.
[52]
Oberley, T.D.; Oberley, L.W. Antioxidant enzyme levels in cancer. Histol. Histopathol., 1997, 12, 525-535.
[53]
Dhar, S.K.; St Clair, D.K. Manganese superoxide dismutase regulation and cancer. Free Radic. Biol. Med., 2012, 52, 2209-2222.
[54]
Hempel, N.; Carrico, P.M.; Melendez, J.A. Manganese superoxide dismutase (sod2) and redox-control of signaling events that drive metastasis. Anticancer. Agents Med. Chem., 2011, 11, 191-201.
[55]
Papa, L.; Hahn, M.; Marsh, E.L.; Evans, B.S.; Germain, D. Sod2 to sod1 switch in breast cancer. J. Biol. Chem., 2014, 289, 5412-5416.
[56]
Papa, L.; Manfredi, G.; Germain, D. Sod1, an unexpected novel target for cancer therapy. Genes Cancer, 2014, 5, 15-21.
[57]
Huang, P.; Feng, L.; Oldham, E.A.; Keating, M.J.; Plunkett, W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature, 2000, 407, 390-395.
[58]
Yilmaz, N.; Dulger, H.; Kiymaz, N.; Yilmaz, C.; Bayram, I.; Ragip, B.; Oger, M. Lipid peroxidation in patients with brain tumor. Int. J. Neurosci., 2006, 116, 937-943.
[59]
Gauchez, A.S.; Riondel, J.; Jacrot, M.; Calop, J.; Favier, A. Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors. Biol. Trace Elem. Res., 1995, 47, 103-109.
[60]
Rao, G.M.; Rao, A.V.; Raja, A.; Rao, S.; Rao, A. Role of antioxidant enzymes in brain tumours. Clin. Chim. Acta, 2000, 296, 203-212.
[61]
Chu, F.F. The human glutathione peroxidase genes gpx2, gpx3, and gpx4 map to chromosomes 14, 5, and 19, respectively. Cytogenet. Cell Genet., 1994, 66, 96-98.
[62]
Esworthy, R.S.; Doan, K.; Doroshow, J.H.; Chu, F.F. Cloning and sequencing of the cdna encoding a human testis phospholipid hydroperoxide glutathione peroxidase. Gene, 1994, 144, 317-318.
[63]
Hall, L.; Williams, K.; Perry, A.C.; Frayne, J.; Jury, J.A. The majority of human glutathione peroxidase type 5 (gpx5) transcripts are incorrectly spliced: Implications for the role of gpx5 in the male reproductive tract. Biochem. J., 1998, 333(Pt 1), 5-9.
[64]
Freeman, B.A.; Crapo, J.D. Biology of disease: Free radicals and tissue injury. Lab. Invest., 1982, 47, 412-426.
[65]
Meister, A. Glutathione, ascorbate, and cellular protection. Cancer Res., 1994, 54, 1969s-1975s.
[66]
Baliga, M.S.; Diwadkar-Navsariwala, V.; Koh, T.; Fayad, R.; Fantuzzi, G.; Diamond, A.M. Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol. Nutr. Food Res., 2008, 52, 1300-1304.
[67]
Lei, X.G.; Cheng, W.H.; McClung, J.P. Metabolic regulation and function of glutathione peroxidase-1. Annu. Rev. Nutr., 2007, 27, 41-61.
[68]
Zhuo, P.; Diamond, A.M. Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim. Biophys. Acta, 2009, 1790, 1546-1554.
[69]
Yagublu, V.; Arthur, J.R.; Babayeva, S.N.; Nicol, F.; Post, S.; Keese, M. Expression of selenium-containing proteins in human colon carcinoma tissue. Anticancer Res., 2011, 31, 2693-2698.
[70]
Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med., 2000, 29, 323-333.
[71]
Amstad, P.; Peskin, A.; Shah, G.; Mirault, M.E.; Moret, R.; Zbinden, I.; Cerutti, P. The balance between cu, zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry, 1991, 30, 9305-9313.
62
5